Publication | Closed Access
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study
210
Citations
19
References
2018
Year
Tumoral PathologyMedicineMetronomic TherapyPathologyCancer TreatmentOncologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1